ClinicalTrials.gg
Not yet recruitingNCT07402603Updated Feb 11, 2026

Sleep-disordered Breathing Database

An observational study in Obstructive Sleep Apnoea (OSA) and Hypoventilation Syndrome, sponsored by Royal Free Hospital NHS Foundation Trust. Not yet recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-11.

Sponsored by Royal Free Hospital NHS Foundation Trust · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
5,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 54 studies in Sleep Apnea, Obstructive with a site in United Kingdom — 9 open to participants now, 13 under way, none of them phase 3. Sleep Apnea, Obstructive · United Kingdom.

Planned enrollment
3rd of 28
5,000 · median 102
Started
2026
with 2 others
Observational
28 of 54
6 open now
Primary completion
2031-01
later than 11 of 12 live
Registered
52nd of 54
by date
Lead sponsor
2 of 54
Royal Free Hospital NHS Foundation Trust

Among the 54 studies in Sleep Apnea, Obstructive with a site in United Kingdom, this one is the 3rd largest by planned enrollment of the 28 observational ones that give a count, is one of 3 that started in 2026, is one of 28 observational ones, reaches primary completion later than 11 of the 12 other live ones, and was the 52nd registered.

Sleep Apnea, Obstructive

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

9 of the 54 studies in Sleep Apnea, Obstructive with a site in United Kingdom are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies in Sleep Apnea, Obstructive with a site in United Kingdom, or all of them as a file.
02

Study summary

The goal of this study is to collect clinical data on patients who have had a sleep study and are given a diagnosis of a sleep related breathing disorder such as obstructive sleep apnoea. Collecting this data in an organised way will mean that the investigators can monitor patients and their health outcomes.

Read the detailed description

This is a prospective database collecting: symptom, physiological, comorbidity and treatment response data

03

Conditions studied

  • Obstructive Sleep Apnoea (OSA)
  • Hypoventilation Syndrome

Keywords

  • database
  • observational
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The patient population will be those patients under the sleep and ventilation service who have undertaken a sleep study and started on treatment for their sleep disordered breathing

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age >18 years
  • Referred to Royal Free London NHS Foundation Trust Sleep and Ventilation Service
  • Agreed to undertake a sleep study

Exclusion criteria

Exclusion Criteria:

  • Inability to consent
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
5,000 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • Sleep disordered breathing

    Patients who are referred for a sleep study to investigate sleep disordered breathing

06

What researchers measure

Primary outcomes

  1. Number of patients consenting to participation in a database

    From the whole cohort referred for a sleep study, the number of participants (percentage of the whole cohort) who sign a consent form and have data recorded will be calculated

    Time frame: 5 years

Secondary outcomes

  1. Changes in symptoms and disease related variables

    Changes in symptom based scores - Epworth sleepiness score between baseline and follow up Changes in disease parametrics including: AHI (apnoea/hypopnoea index), blood gas measurements (PO2, PCO2, pH, HCO3), lung function between baseline and follow up Additional variables may be added over the duration of the database

    Time frame: 5 years initially, further ethical approval will be sought at 5 years to extend the database further

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided — Other researchers may apply for access to the database, provided they demonstrate a valid scientific and public benefit and meet all governance requirements.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2026; primary completion for Jan 2031, 59 months later.

Of 258 non-industry observational studies under Sleep Apnea, Obstructive, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 63. This study's planned 59 months is above that.

Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 14 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2026
First posted
Feb 11, 2026
StartEst.
Jan 15, 2026
Primary completionEst.
Jan 14, 2031
CompletionEst.
Jan 2036
Last update
Feb 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07402603
Lead sponsor
Royal Free Hospital NHS Foundation Trust
Responsible party
Sponsor
First posted
Feb 11, 2026
Start date
Jan 15, 2026 (estimated)
Primary completion
Jan 14, 2031 (estimated)
Completion
Jan 2036 (estimated)
Last update
Feb 11, 2026

Study contacts

Swapna Mandal, PhD
Contact
swapnamandal@nhs.net
+442077940500 ext. 23359
Amar Shah, PhD
Contact
amar.shah5@nhs.net
+442077940500 ext. 23359

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion